U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07355725) titled 'To Evaluate the Efficacy of Lutemax 2020 on Vision and Cognitive Performance in Health Children.' on Feb. 10, 2023.
Brief Summary: To address the detrimental effects of the sudden rise in the use of digital devices leading to increased screen time, the present study will assess the efficacy of macular carotenoid supplementation Lutemax 2020 in young children
Study Start Date: July 21, 2022
Study Type: INTERVENTIONAL
Condition:
Cognitive
Intervention:
DIETARY_SUPPLEMENT: Lutemax 2020 gummies
Lutein 10 mg & Zeaxanthin isomers 2 mg
OTHER: Placebo
Placebo gummies
Recruitment Status: COMPLETED
Sponsor: Bioagile Therapeutics Pv...